Ayurvedic medicines still continue to be viewed as only a niche alternative to mainstream allopathic drugs. Baidyanath scion Ameve Sharma and entrepreneur Shrey Badhani set out to change this perception in 2015 via Kapiva Ayurveda, with a range of wellness products with both FDA (the US drug regulator) and GMP (Good Manufacturing Practice) certification.
“The products stemmed from a need to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer. While both of us grew up on a steady dose of Ayurveda, we felt friends and colleagues in our age group did not trust the products, as they were not uniformly certified,” said Sharma.
Over the past three months, Kapiva Ayurveda has got in strategic investors, diluting almost 10 per cent